• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    (OP: NUMIF )

    0.0201 +0.0005 (+2.55%)
    Streaming Delayed Price Updated: 2:50 PM EDT, Oct 31, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about NUMIF

    Global Psychedelic Therapeutics Market Size Expected To Reach $13.29 Billion By The Year 2031
    EQNX::TICKER_START (NYSE:CYBN),NEO:CYBN),(NASDAQ:CMPS),(NASDAQ:MNMD),(NASDAQ:SEEL),(OTCQX:NUMIF) EQNX::TICKER_END 
    Via FinancialNewsMedia
    Small Cap Growth Virtual Investor Conference: Presentations Now Available for Online Viewing
    Company Executives Share Vision and Answer Questions at VirtualInvestorConferences.com 
    From Virtual Investor Conferences
    Via GlobeNewswire
    Small Cap Growth Virtual Investor Conference Agenda Announced for July 13th
    Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
    From Virtual Investor Conferences
    Via GlobeNewswire
    Numinus Expands Research Capabilities with new Phoenix Clinical Research Site
    The Phoenix Site is Numinus’ Third Research Facility in the US VANCOUVER, BC, Feb. 17, 2023 – Numinus Wellness Inc. (“Numinus”) (TSX:NUMI) (OTCQX:NUMIF), a mental health care company advancing... 
    Via PressReach
    Numinus Wellness Inc. Reports Q1 2023 Results
    Q1 2023 revenues grew 618% year-over-year to $5.7 million Q1 2023 gross margin grew to 41.9% from 31.5% in prior quarter Gross profit of $2.4 million, an increase of $1.1 million from prior quarter... 
    Via PressReach
    KCSA Mental Health Virtual Investor Conference: Presentations Now Available for Online Viewing
    Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
    From Virtual Investor Conferences
    Via GlobeNewswire
    KCSA Mental Health Virtual Investor Conference Agenda Announced for December 15th
    Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
    From Virtual Investor Conferences
    Via GlobeNewswire
    Numinus Submits Clinical Trial Application to Health Canada for Experiential Psilocybin-Assisted Therapy Training Research
    New clinical trial will provide experiential training to therapists learning to conduct psilocybin-assisted therapy. Clinical trial dosing will use Numinus Bioscience’s Psilocybin Tea, EnfiniTea – one... 
    Via PressReach
    Numinus Wellness Inc. Reports Q4 2022 and Annual Results
    Q4 2022 revenues grew 643% year-over-year to $4.2 million Q4 2022 gross margin grew to 31.5%, generated $1.3 million of gross profit Completed acquisition of Novamind, positioning Numinus as a leading,... 
    Via PressReach
    Numinus Launches Psychedelic-Assisted Therapy for Chronic and Serious Medical Illness
    a documentary following the journey of a patient undergoing psychedelic-assisted therapy to treat end-of-life distress. Additionally, since Numinus' 
    Via PressReach
    New Study Reveals Psychedelic Drugs Can Be Almost as Life-Changing as Near-Death Experiences
    A new study undertaken by experts at John Hopkins University School of Medicine has revealed that taking psychedelics can have the same transformational effects as a near-death experience (NDE). The... 
    Via PressReach
    Topics Supply Chain
    Exposures Supply Chain
    Colorado to Vote on Legalizing Psychoactives in November
    Voters in Colorado will have a say in the legalization of psychedelic drugs this November as an initiative to legalize psilocybin mushrooms and other naturally occurring psychedelics appears on the... 
    Via PressReach
    Topics Supply Chain
    Exposures Supply Chain
    Scientists Are Studying Psychedelic Drug as a Possible Treatment for Alzheimer’s Disease
    A Toronto-based biotech firm is developing a new psychedelic medicine to cure Alzheimer’s disease, announcing recently that it has gotten approval from Argentina’s regulators to begin a Phase ll... 
    Via PressReach
    Topics Cannabis
    Exposures Cannabis
    New Study Reveals Psychedelic Drugs Can Be Almost as Life-Changing as Near-Death Experiences
    FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – October 5, 2022 – A new study undertaken by experts at John Hopkins University School of Medicine has revealed that taking... 
    Via FinancialNewsMedia
    Mental Health Claims up 75% Since 2019
    Canadian health insurers processed nearly $600 million in mental health service claims in 2021, up 75% from 2019 as more Canadians tapped into their mental health benefits. According to the Canadian... 
    Via PressReach
    Mental Health Claims up 75% Since 2019
    FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – September 23, 2022 – Canadian health insurers processed nearly $600 million in mental health service claims in 2021, up 75%... 
    Via FinancialNewsMedia
    Numinus Opens New Clinic in Montreal to Increase Access to Ketamine Therapy for Mental Health
    Mental healthcare company Numinus Wellness Inc. (TSX:NUMI) (OTCQX:NUMIF) is focused on helping people heal by developing and delivering innovative treatments and safe, evidence-based... 
    Via PressReach
    Atlanta Becomes Latest City to Consider Decriminalizing Psychedelics
    Atlanta just became the latest city to consider decriminalizing psychedelics. On September 12, just one week after San Francisco officially decriminalized psychedelics, a meeting was held by the City... 
    Via PressReach
    Atlanta Becomes Latest City to Consider Decriminalizing Psychedelics
    FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – September 22, 2022 – Atlanta just became the latest city to consider decriminalizing psychedelics. On September 12, just one... 
    Via FinancialNewsMedia
    Psychedelics Use Among Young Adults Reaches All-Time High
    FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – September 1, 2022 – Young adults are using more hallucinogens than ever. According to a National Institute of Health survey,... 
    Via FinancialNewsMedia
    World’s Richest Man Says Psychedelics Could Make a Real Difference in Mental Health
    FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – June 15, 2022 – Elon Musk believes that psychedelics and other plant-based drugs are better than pharma meds in treating a... 
    Via FinancialNewsMedia
    American Billionaire Entrepreneurs Bet Millions on Psychedelics
    FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – May 10, 2022 – Billionaire Bob Parsons, the founder of GoDaddy, believes psychedelics can heal trauma. The Marine infantryman... 
    Via FinancialNewsMedia
    Exposures Product Safety
    Roth Capital Reveals Top Psychedelic Picks in New Industry Report
    FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – April 21, 2022 – Investment banks are continuing to release positive coverage for psychedelic stocks and the latest report... 
    Via FinancialNewsMedia
    Demand for Toad Venom Rises Along With the Booming Psychedelics Market
    FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – March 30, 2022 – Depression and anxiety affect millions around the world and the venom of a toad is the latest psychedelic... 
    Via FinancialNewsMedia
    Psilocybin and MDMA Get the Green Light for Medical Use in Canada
    FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – January 19, 2022 – After facing legal scrutiny for decades, psychedelics including MDMA and psilocybin received a stamp of... 
    Via FinancialNewsMedia
    Why Some Psychedelic Assisted Therapy Clinics Are Turning To Artificial Intelligence for Digital Mental Therapies
    Palm Beach, FL –December 16, 2021 – FinancialNewsMedia.com News Commentary – Drugs like ketamine and psilocybin — the active ingredient in magic mushrooms — are showing real promise in addressing... 
    Via FinancialNewsMedia
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.